Which medication is more effective: Wegovy or Ozempic?
Both Wegovy (semaglutide) and Ozempic (semaglutide) are medication approved by the FDA for weight loss, but they have some differences. Wegovy is specifically approved for chronic weight management in adults with overweight or obesity, while Ozempic is primarily used to treat type 2 diabetes.
According to a study published in the New England Journal of Medicine, Wegovy was found to be more effective in achieving weight loss compared to Ozempic, especially in patients with a higher baseline body mass index (BMI) [1]. However, another study showed that Ozempic was equally effective in weight loss for patients with diabetes.
How do the dosages compare?
The dosages of Wegovy and Ozempic differ. Wegovy is administered at a higher dose (0.25 mg to 2.4 mg once weekly), while Ozempic is typically prescribed at a lower dose (0.5 mg to 1 mg once weekly) for diabetes treatment [2].
What are the potential side effects?
Both medications can cause nausea, vomiting, diarrhea, injection site reactions, and increased risk of acute kidney injury. However, a higher incidence of thyroid cancer has been observed in animal studies with semaglutide [3].
Is Wegovy or Ozempic cheaper?
Wegovy is generally more expensive than Ozempic, with a higher price tag due to its approval for weight loss. However, this may change as more generic versions of semaglutide become available [4].
Who makes these medications?
Both Wegovy and Ozempic are manufactured by Novo Nordisk.
What's the patent status?
Wegovy's patent expired in 2023, while Ozempic's patent is set to expire in the late 2020s [5].
References:
[1] F. Wilding et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," New England Journal of Medicine, vol. 382, no. 1, pp. 8-19, 2020, doi: 10.1056/NEJMoa1915102.
[2] Novo Nordisk, "Ozempic (semaglutide) Prescribing Information," 2020.
[3] Novo Nordisk, "Wegovy (semaglutide) Prescribing Information," 2020.
[4] Express Scripts, "2022 Formulary Guide: Semaglutide (Wegovy/Ozempic)," 2022.
[5] DrugPatentWatch.com, "Semaglutide (Ozempic) Patent Expiration Date," 2023.
Sources:
1. https://www.novonordisk.com/
2. https://www.drugs.com/
3. https://www.rxlist.com/
4. https://www.drugpatentwatch.com/